KAMELA ROTH: Open Payments
NPI 1033437819 · DOYLESTOWN, PA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$866 in 30 payments from 15 companies in 2025. Trend: 2023 $17 · 2024 $1,166 · 2025 $866
Food & beverage: $866
| Company | Payments | Amount |
|---|---|---|
| Merck Sharp & Dohme LLC | 2 | $126 |
| PFIZER INC. | 1 | $118 |
| AstraZeneca Pharmaceuticals LP | 5 | $106 |
| Eisai Inc. | 4 | $96 |
| Bayer Healthcare Pharmaceuticals Inc. | 3 | $90 |
| Daiichi Sankyo Inc. | 3 | $68 |
| GlaxoSmithKline, LLC. | 3 | $64 |
| Novartis Pharmaceuticals Corporation | 2 | $35 |
| PUMA BIOTECHNOLOGY, INC. | 1 | $30 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $30 |
Products named: ELREXFIO, KEYTRUDA, Lenvima, Nubeqa, Enhertu, CALQUENCE, ZEJULA, NERLYNX.
Industry payments across PA — which companies pay providers there.
